Filter
801
Text search:
rifampicin
Featured
Recommendations
111
New Publications
241
Language
Document type
No document type
566
Guidelines
104
Studies & Reports
61
Manuals
28
Fact sheets
13
Strategic & Response Plan
12
Training Material
9
Situation Updates
4
Infographics
2
App
1
Resource Platforms
1
Countries / Regions
India
57
Western and Central Europe
56
Eastern Europe
32
Nepal
23
South Africa
23
Kenya
19
Tanzania
16
Nigeria
14
Germany
13
Namibia
13
Ethiopia
12
Uganda
12
Zambia
12
Bangladesh
12
Global
11
Malawi
10
Philippines
9
Cambodia
9
Myanmar / Burma
9
South–East Asia Region
9
Latin America and the Carribbean
9
Ukraine
8
Rwanda
7
Asia
7
Russia
6
Eswatini/ Swaziland
5
Africa
5
Tajikistan
5
Indonesia
4
Botswana
4
Sierra Leone
3
Ghana
3
Zimbabwe
3
Pakistan
3
Mozambique
3
Argentina
3
Colombia
3
Lesotho
3
Bhutan
3
Georgia
3
Liberia
2
Senegal
2
Syria
2
Benin
2
Sri Lanka
2
Eastern Europe and Central Asia
2
Armenia
2
Timor Leste/ East Timor
2
Burkina Faso
1
Congo, Democratic Republic of
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Thailand
1
Gambia
1
Malaysia
1
Sudan
1
Brazil
1
North Macedonia
1
Switzerland
1
Serbia
1
Ecuador
1
El Salvador
1
Greece
1
Libya
1
Madagascar
1
Yemen
1
Western Pacific Region
1
Paraguay
1
Fiji
1
Solomon Islands
1
North Korea
1
Albania
1
Laos
1
Romania
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Uruguay
1
Turkmenistan
1
Tunisia
1
Authors & Publishers
Publication Years
Category
Countries
298
Clinical Guidelines
109
Public Health
18
Women & Child Health
18
Capacity Building
16
Pharmacy & Technologies
12
Key Resources
5
Toolboxes
TB
352
HIV
75
NTDs
39
AMR
27
Pharmacy
26
Refugee
15
Polio
10
Ebola
5
Caregiver
5
Conflict
4
COVID-19
4
Mental Health
3
Global Health Education
3
Rapid Response
2
Natural Hazards
1
Guidelines for national programmes and other stakeholders, for annexes see http://www.who.int/tb/publications/2012/tb_hiv_policy_9789241503006/en/
6th edition
Accessed at March 2014
DR-TB drugs under the microscope: Sources and prices for drug-resistant tuberculosis medicines
recommended
4th edition.
This report – now in its fourth edition – analyses the barriers and factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. We provide detailed pricing profiles of key DR-TB drugs, using manufacturer responses to s
...
Accessed at March 2014
guidance for health managers, health workers, and activists
Trainer’s Manual
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information
...